UnitedHealth Group Incorporated (NYSE:UNH) Stake Increased by High Pines Wealth Management LLC

High Pines Wealth Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 38.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 862 shares of the healthcare conglomerate’s stock after purchasing an additional 238 shares during the period. UnitedHealth Group accounts for approximately 0.7% of High Pines Wealth Management LLC’s portfolio, making the stock its 18th biggest holding. High Pines Wealth Management LLC’s holdings in UnitedHealth Group were worth $435,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in UNH. Axiom Financial Strategies LLC acquired a new stake in UnitedHealth Group during the first quarter worth about $210,000. McGowan Group Asset Management Inc. boosted its holdings in UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares in the last quarter. MAS Advisors LLC boosted its holdings in UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after purchasing an additional 45 shares in the last quarter. Finally, First Western Trust Bank acquired a new stake in UnitedHealth Group during the first quarter valued at approximately $875,000. 85.69% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 66,081 shares of the company’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total value of $36,370,321.59. Following the sale, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Morgan Stanley cut their target price on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a research note on Monday, October 23rd. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Royal Bank of Canada restated an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 16th. Finally, StockNews.com cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 21st. One analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $575.79.

Check Out Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Down 0.4 %

NYSE UNH traded down $1.87 on Friday, reaching $518.22. The company had a trading volume of 2,715,493 shares, compared to its average volume of 4,824,929. The firm has a market capitalization of $479.31 billion, a price-to-earnings ratio of 21.74, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The company’s fifty day moving average is $525.36 and its 200-day moving average is $517.72.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the prior year, the business posted $5.34 EPS. The company’s quarterly revenue was up 14.1% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current fiscal year.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.